Patent Infringement, Safe Harbor, and Drug Development

Dr. Feldstein focuses on U.S. district court litigation, primarily concerning the enforcement of U.S. patent rights and trade secret issues, and post-grant trial proceedings at the USPTO, including inter partes review (IPR) and post grant review (PGR). He maintains an active patent prosecution practice, preparing and prosecuting U.S. patent applications on behalf of domestic and foreign clients. He also provides opinions and strategic guidance to clients on infringement, validity, enforceability, and clearance matters. His practice encompasses a range of technologies, including pharmaceuticals, biochemistry, polymers, small molecule chemistry, optics, and medical and analytic devices.

Ms. Holt is an experienced patent litigator at both the appellate and trial levels. A former clerk at the U.S. Court of Appeals for the Federal Circuit, she represents clients in patent disputes before the Federal Circuit, the U.S. Supreme Court, and district courts across the country. Ms. Holt handles cases involving a variety of technologies, with an emphasis on the biotechnology, pharmaceutical, and life sciences industries. She also assists clients in portfolio counseling matters and proceedings before the U.S. Patent and Trademark Office (USPTO).

Dr. Stewart is a Vice-President at Merck Sharp & Dohme and is the head of Merck’s global IP litigation group. He has more than 25 years of experience working as in-house counsel in the pharmaceutical industry. His experience has ranged from drafting and prosecuting patent applications, corporate transactions, due diligence work, and global patent litigation. Dr. Stewart has a Ph.D. in Biochemistry from Colorado State University and did postdoctoral work both at the University of Michigan and Indiana University. He received his law degree and was an adjunct professor for a number of years at the Indiana University McKinney School of Law.